|
Market Closed -
CBOE
09:00:00 21/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 131.66 EUR | +2.36% |
|
-0.29% | +21.49% |
| 18/09 | Dr. Reddy's Confirms License for Gilead's Yearly-Once HIV Drug; Shares Up 2% | MT |
| 17/09 | Gilead Sciences Insider Sold Shares Worth $432,646, According to a Recent SEC Filing | MT |
| Market Cap | 19TCr 16TCr 15TCr 14TCr 26TCr 17,83200Cr 26TCr 1,83100Cr 70TCr 9,08300Cr 70TCr 68TCr 29,28800Cr | P/E 2026 * |
-45.4x | P/E 2027 * | 18.7x |
|---|---|---|---|---|---|
| Enterprise Value | 20TCr 18TCr 17TCr 15TCr 28TCr 19,43600Cr 28TCr 1,99600Cr 77TCr 9,90000Cr 76TCr 75TCr 31,92300Cr | EV / Sales 2026 * |
6.61x | EV / Sales 2027 * | 5.97x |
| Free-Float |
99.88% | Yield 2026 * |
2.19% | Yield 2027 * | 2.23% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| GILD | Delayed | |
CBOE
| GILD | Real-time | |
|
Tradegate
| GIS | Real-time | |
|
Xetra
| GIS | Delayed | |
|
Mexican S.E.
| GILD * | End-of-day quote | |
|
Boerse Muenchen
| GIS | Real-time | |
|
Deutsche Boerse AG
| GIS | Delayed | |
|
Borsa Italiana
| 1GILD | End-of-day quote | |
|
CBOE
| Real-time | ||
|
Wiener Boerse
| GILD | End-of-day quote | |
|
London S.E.
| 0QYQ | Delayed | |
|
Börse Stuttgart
| GIS | Delayed | |
|
Santiago S.E.
| GILD | End-of-day quote | |
|
Swiss Exchange
| GILD | Delayed | |
|
Lima
| GILDUS | End-of-day quote | |
|
Santiago S.E.
| GILDCL | End-of-day quote | |
|
Swiss Exchange
| GILD | Delayed | |
|
CBOE
| 0QYQ | Real-time |
Last Transcript: Gilead Sciences, Inc.
| 1 week | +2.05% | ||
| Current month | +4.55% | ||
| 1 month | +4.64% | ||
| 3 months | +20.50% | ||
| 6 months | +8.61% | ||
| Current year | +24.35% |
| 1 week | 125.72 |  | 131.66 |
| 1 month | 124.2 | | 131.66 |
| 3 years | 58.35 | | 131.66 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 61 | 01/03/2019 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 01/11/2019 |
Keeley Wettan
CMP | Compliance Officer | - | 18/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 58 | 19/08/2016 |
| Director/Board Member | 73 | 01/01/2018 | |
Harish Manwani
BRD | Director/Board Member | 72 | 09/05/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.36% | -0.29% | +37.33% | +86.86% | 19TCr | |
| +1.04% | +4.41% | +54.91% | +104.50% | 1,02800Cr | |
| -0.19% | +1.46% | +52.94% | +65.41% | 65TCr | |
| +0.20% | +2.86% | +18.88% | +72.18% | 47TCr | |
| +2.24% | +5.98% | +37.61% | +42.44% | 35TCr | |
| +0.90% | +3.66% | +18.79% | +25.03% | 27TCr | |
| +0.48% | +7.28% | +11.11% | +14.70% | 26TCr | |
| +1.95% | +4.19% | +37.75% | +44.83% | 21TCr | |
| -7.65% | -5.95% | -33.09% | -60.76% | 19TCr | |
| +0.30% | +4.76% | +31.97% | +98.58% | 19TCr | |
| Average | -0.16% | +3.26% | +26.82% | +49.38% | 40.02TCr | |
| Weighted average by Cap. | +0.11% | +3.09% | +35.65% | +63.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.07TCr 2.68TCr 2.52TCr 2.3TCr 4.31TCr 2,94100Cr 4.31TCr 30TCr 12TCr 1,49800Cr 12TCr 11TCr 4,83100Cr | 3.27TCr 2.85TCr 2.68TCr 2.44TCr 4.59TCr 3,13100Cr 4.59TCr 32TCr 12TCr 1,59500Cr 12TCr 12TCr 5,14300Cr |
| Net income | -427.47Cr -372.87Cr -350.89Cr -319.74Cr -599.83Cr -41TCr -600.31Cr -4.21TCr -1.62TCr -21TCr -1.61TCr -1.57TCr -67TCr | 1.03TCr 896.27Cr 843.41Cr 768.55Cr 1.44TCr 98TCr 1.44TCr 10TCr 3.89TCr 50TCr 3.86TCr 3.77TCr 1,61700Cr |
| Net Debt | 1.67TCr 1.46TCr 1.37TCr 1.25TCr 2.35TCr 1,60400Cr 2.35TCr 16TCr 6.34TCr 82TCr 6.29TCr 6.15TCr 2,63500Cr | 912.45Cr 795.91Cr 748.98Cr 682.5Cr 1.28TCr 87TCr 1.28TCr 8.98TCr 3.46TCr 45TCr 3.43TCr 3.35TCr 1,43600Cr |
| Date | Price | Change |
|---|---|---|
| 21/26/21 | €131.66 | +2.36% |
| 18/26/18 | €128.63 | 0.00% |
| 17/26/17 | €128.63 | +2.20% |
| 16/26/16 | €125.86 | 0.00% |
| 15/26/15 | €125.86 | -2.44% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
Select your edition
All financial news and data tailored to specific country editions
